Investigating how glypicans affect eye pressure and glaucoma
Role of Glypicans in Trabecular Meshwork Function, IOP, and Glaucoma
This study is looking at a protein called glypican-4 to see how it helps the eye's drainage system work better, which could lead to new treatments for lowering eye pressure and preventing glaucoma-related vision loss.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Duke University NIH-funded |
| Lab location | 1 site (Durham, United States) |
| Project ID | NIH-10939330 on NIH RePORTER |
What this research studies
This research focuses on understanding the role of glypicans, specifically glypican-4, in the function of the trabecular meshwork, which is crucial for regulating intraocular pressure (IOP). By examining how these proteins influence cell adhesion and actomyosin activity, the study aims to identify new molecular targets for developing treatments that can lower IOP and potentially prevent glaucoma-related blindness. The approach includes both cellular and molecular analyses to uncover the mechanisms behind these processes. Patients may benefit from new therapies that arise from this research, which could lead to more effective management of glaucoma.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals at risk of glaucoma, particularly those with ocular hypertension.
Not a fit: Patients with glaucoma who are already receiving effective treatment may not see additional benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to new treatments that effectively lower eye pressure and reduce the risk of glaucoma-related blindness.
How similar studies have performed: Previous research has shown promise in targeting molecular mechanisms related to IOP regulation, suggesting that this approach could lead to significant advancements in glaucoma treatment.
Where this research is happening
Durham, United States
- Duke University — Durham, United States (Active)
Researchers
- Principal investigator: Rao, P Vasantha — Duke University
- Study coordinator: Rao, P Vasantha
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.